Cotellic (Genentech, Inc.)
Welcome to the PulseAid listing for the Cotellic drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | COBIMETINIB |
SUBSTANCE NAME: | COBIMETINIB FUMARATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2015-11-10 |
END MARKETING DATE: | 0000-00-00 |
Cotellic HUMAN PRESCRIPTION DRUG Details:
Item Description | Cotellic from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2015-11-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50242-717_6b81242b-c615-4160-81c7-ee645515b29d |
PRODUCT NDC: | 50242-717 |
APPLICATION NUMBER: | NDA206192 |
Other COBIMETINIB FUMARATE Pharmaceutical Manufacturers / Labelers: